GB9017479D0 - Process - Google Patents

Process

Info

Publication number
GB9017479D0
GB9017479D0 GB909017479A GB9017479A GB9017479D0 GB 9017479 D0 GB9017479 D0 GB 9017479D0 GB 909017479 A GB909017479 A GB 909017479A GB 9017479 A GB9017479 A GB 9017479A GB 9017479 D0 GB9017479 D0 GB 9017479D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB909017479A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to GB909017479A priority Critical patent/GB9017479D0/en
Publication of GB9017479D0 publication Critical patent/GB9017479D0/en
Priority to IE240691A priority patent/IE912406A1/en
Priority to IL98833A priority patent/IL98833A0/en
Priority to GB919115250A priority patent/GB9115250D0/en
Priority to ZA915567A priority patent/ZA915567B/en
Priority to CA002047249A priority patent/CA2047249A1/en
Priority to CN91105053A priority patent/CN1058965A/en
Priority to KR1019920700813A priority patent/KR920702357A/en
Priority to JP3513216A priority patent/JPH05501728A/en
Priority to PCT/GB1991/001287 priority patent/WO1992002508A1/en
Priority to AU83090/91A priority patent/AU8309091A/en
Priority to EP91914106A priority patent/EP0495948A1/en
Priority to HU92933A priority patent/HUT60490A/en
Priority to PT98607A priority patent/PT98607A/en
Priority to MX9100581A priority patent/MX9100581A/en
Priority to CS92886A priority patent/CS88692A3/en
Priority to FI921319A priority patent/FI921319A/en
Priority to NO92921389A priority patent/NO921389L/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
GB909017479A 1990-08-09 1990-08-09 Process Pending GB9017479D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB909017479A GB9017479D0 (en) 1990-08-09 1990-08-09 Process
IE240691A IE912406A1 (en) 1990-08-09 1991-07-09 Process
IL98833A IL98833A0 (en) 1990-08-09 1991-07-15 Preparation of quinoline derivatives
GB919115250A GB9115250D0 (en) 1990-08-09 1991-07-16 Process
ZA915567A ZA915567B (en) 1990-08-09 1991-07-16 Process for the manufacture of quinoline derivatives
CA002047249A CA2047249A1 (en) 1990-08-09 1991-07-17 Process
CN91105053A CN1058965A (en) 1990-08-09 1991-07-24 The method for preparing new quinoline
HU92933A HUT60490A (en) 1990-08-09 1991-07-30 Process for producing quinoline derivatives
JP3513216A JPH05501728A (en) 1990-08-09 1991-07-30 Production method of quinoline derivatives
KR1019920700813A KR920702357A (en) 1990-08-09 1991-07-30 Method for preparing quinoline derivative
PCT/GB1991/001287 WO1992002508A1 (en) 1990-08-09 1991-07-30 Process for the manufacture of quinoline derivatives
AU83090/91A AU8309091A (en) 1990-08-09 1991-07-30 Process for the manufacture of quinoline derivatives
EP91914106A EP0495948A1 (en) 1990-08-09 1991-07-30 Process for the manufacture of quinoline derivatives
PT98607A PT98607A (en) 1990-08-09 1991-08-08 PROCESS FOR THE PREPARATION OF QUINOLINE DERIVATIVES
MX9100581A MX9100581A (en) 1990-08-09 1991-08-08 PROCESS
CS92886A CS88692A3 (en) 1990-08-09 1992-03-24 Process for preparing quinoline derivatives
FI921319A FI921319A (en) 1990-08-09 1992-03-26 FOERFARANDE FOER FRAMSTAELLNING AV KINOLINDERIVAT.
NO92921389A NO921389L (en) 1990-08-09 1992-04-08 PROCEDURE FOR THE PREPARATION OF QUINOLINE DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909017479A GB9017479D0 (en) 1990-08-09 1990-08-09 Process

Publications (1)

Publication Number Publication Date
GB9017479D0 true GB9017479D0 (en) 1990-09-26

Family

ID=10680406

Family Applications (2)

Application Number Title Priority Date Filing Date
GB909017479A Pending GB9017479D0 (en) 1990-08-09 1990-08-09 Process
GB919115250A Pending GB9115250D0 (en) 1990-08-09 1991-07-16 Process

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB919115250A Pending GB9115250D0 (en) 1990-08-09 1991-07-16 Process

Country Status (15)

Country Link
EP (1) EP0495948A1 (en)
JP (1) JPH05501728A (en)
KR (1) KR920702357A (en)
CN (1) CN1058965A (en)
AU (1) AU8309091A (en)
CA (1) CA2047249A1 (en)
CS (1) CS88692A3 (en)
FI (1) FI921319A (en)
GB (2) GB9017479D0 (en)
HU (1) HUT60490A (en)
IE (1) IE912406A1 (en)
IL (1) IL98833A0 (en)
PT (1) PT98607A (en)
WO (1) WO1992002508A1 (en)
ZA (1) ZA915567B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246944A (en) * 1991-08-13 1993-09-21 Merck & Co., Inc. Quinoline angiotensin ii antagonists incorporating a substituted benzyl element
US5484955A (en) * 1992-07-06 1996-01-16 Takeda Chemical Industries, Ltd. Tri-higher alkyl tin azide and its use
US6608048B2 (en) 2000-03-28 2003-08-19 Wyeth Holdings Tricyclic protein kinase inhibitors
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (en) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014274812B2 (en) 2013-06-05 2018-09-27 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase C, method of making and using same
MY191804A (en) 2013-09-16 2022-07-15 Astrazeneca Ab Therapeutic polymeric nanoparticles and methods of making and using same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4920132A (en) * 1987-11-03 1990-04-24 Rorer Pharmaceutical Corp. Quinoline derivatives and use thereof as antagonists of leukotriene D4
FI903966A0 (en) * 1989-08-11 1990-08-10 Ici Plc KVAEVEFOERENINGAR.

Also Published As

Publication number Publication date
FI921319A0 (en) 1992-03-26
CA2047249A1 (en) 1992-02-10
GB9115250D0 (en) 1991-08-28
HU9200933D0 (en) 1992-05-28
ZA915567B (en) 1992-07-29
EP0495948A1 (en) 1992-07-29
CN1058965A (en) 1992-02-26
JPH05501728A (en) 1993-04-02
PT98607A (en) 1992-06-30
AU8309091A (en) 1992-03-02
FI921319A (en) 1992-03-26
HUT60490A (en) 1992-09-28
KR920702357A (en) 1992-09-03
IL98833A0 (en) 1992-07-15
CS88692A3 (en) 1992-10-14
WO1992002508A1 (en) 1992-02-20
IE912406A1 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
GB9113287D0 (en) Process
EP0475731A3 (en) Development process
GB9022127D0 (en) Process
GB9022787D0 (en) Process
AP9100251A0 (en) Process
GB9017479D0 (en) Process
GB9009000D0 (en) Novel process
HU913311D0 (en) Deparaffinizating process
GB9026926D0 (en) Novel process
EP0443796A3 (en) Development process
GB9004390D0 (en) Process
GB9014851D0 (en) Process
GB9013699D0 (en) New process
RO105801B1 (en) Ppreparation process for alhylcyclohexanols
GB9014234D0 (en) Preparation process
GB9019864D0 (en) Process
GB9019142D0 (en) Process
GB9021663D0 (en) Process
GB9021662D0 (en) Process
GB9023291D0 (en) Process
GB9023300D0 (en) Process
GB9025680D0 (en) Process
GB9021455D0 (en) Process
GB9020856D0 (en) Process
GB9026426D0 (en) Process